Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/18605Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Giannakopoulos, X. | en |
| dc.contributor.author | Kalfakakou, V. | en |
| dc.contributor.author | Tsoumanis, P. | en |
| dc.contributor.author | Karkabounas, S. | en |
| dc.contributor.author | Giannakis, D. | en |
| dc.contributor.author | Chambilomatis, P. | en |
| dc.contributor.author | Evangelou, A. | en |
| dc.contributor.author | Kallistratos, G. | en |
| dc.date.accessioned | 2015-11-24T18:53:46Z | - |
| dc.date.available | 2015-11-24T18:53:46Z | - |
| dc.identifier.issn | 0248-0018 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/18605 | - |
| dc.rights | Default Licence | - |
| dc.subject | Adult | en |
| dc.subject | Aged | en |
| dc.subject | Cystine/analysis | en |
| dc.subject | Cystinuria/complications/drug therapy | en |
| dc.subject | Female | en |
| dc.subject | Follow-Up Studies | en |
| dc.subject | Humans | en |
| dc.subject | Male | en |
| dc.subject | Middle Aged | en |
| dc.subject | Recurrence | en |
| dc.subject | Tiopronin/administration & dosage/therapeutic use | en |
| dc.subject | Urinary Calculi/chemistry/complications/drug therapy/radiography | en |
| dc.subject | Urography | en |
| dc.title | Results of treatment of cystinuria and cystine lithiasis with alpha-mercaptopropionylglycine. Apropos of 40 patients | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/7836789 | - |
| heal.language | fr | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 1994 | - |
| heal.abstract | From 1987 to 1990, 719 subjects (385 males and 334 females) were screened, by means of urocystin-kit, for cystinuria and cystine lithiasis, in Epirus district (North-West Greece). The positive results were confirmed by chromatographic analysis of urine amino acids and laboratory tests. Forty patients, belonging to six cystinuric families, were identified. These patients were excreting 3.1 +/- 1.7 mmol/24 h of cystine in urine. All patients were treated by per os administration of alpha-MPG in daily doses of 400-1,200 mg/24 h). We therefore report the results of a 4 +/- 2 year follow-up of these patients. We conclude that treatment with alpha-MPG is very effective with minimal side effects in patients suffering from cystinuria or cystine urinary calculi. | en |
| heal.journalName | J Urol (Paris) | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
There are no files associated with this item.
This item is licensed under a Creative Commons License
